| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.3 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |